Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification to enhance binding affinity to specific enzyme targets. Commonly employed in research settings to design bioactive molecules with improved metabolic stability and potency. Also utilized in the preparation of labeled derivatives for drug metabolism studies.